Tridge Logo
Tridge Agent System
← Back to Deals

Forecast 및 Next Action

핵심 마일스톤에 따라 다음 액션이 자동으로 결정됩니다.

Forecast (effective)Unratedrecommended
Baseline date → Current date
—→none
Source: none
Next ActionSales Action finishedManaged separately under Collection
Baseline amount → Current amount
—→—

세일즈 진행 전 필수로 파악해야 할 정보입니다.

모든 세일즈 활동을 기록해서 딜을 관리하세요.

딜 워크스페이스

deal-8d59e86a
AVOCADO HEALTH · United States (US)
📡 Signal 0D · 1S long_silence — 자동 종료: 제안서 전송 전 단계에서 60일 동안 고객 회신 없음
관심도
아웃리치
04/18 13:31
답장 수신
04/18 13:31
딜 생성
04/18 13:31
담당자 배정
04/20 10:22
AE 첫 연락
-
첫 미팅 예약
-
Discovery
Discovery Meeting Completed
04/27 14:01
가치 제안
가치 제안 미팅 완료
-
제안서
제안서 발송
-
협상
협상 완료
-
계약서 발송
-
계약 진행
계약 서명
-
첫 결제 완료
-
수주 완료
최종 결제 완료
-

판매 제품

이 딜에서 제안할 제품을 선택하세요. 제품을 선택하면 해당 제품의 딜 금액 옵션이 표시됩니다.

미설정

딜 참여자

이메일을 주고받을 고객 연락처를 등록하세요.

Tridge 담당자
AE Justin Roh (justin.roh@tridge.com) Primary
BDR —
+ AE 추가
고객 연락처
1 Andrew Logan (andrew@avohealth.com) 대표
+ 고객 연락처 추가
미팅 이력
추가 미팅 기록이 필요하면 우측 버튼을 이용하세요.
아직 미팅 이력이 없습니다.

전송된 제안서

제안서 링크 및 첨부파일

아직 제안서 기록이 없습니다.

서명된 계약서

계약서 링크 및 첨부파일

아직 계약서 기록이 없습니다.

결제 이력

분할 납부 일정에서 실제 입금을 기록한 이력입니다.

아직 결제 이력이 없습니다.

활동 기록

1
Drop 2026/10/16 17:51

자동 종료: 제안서 전송 전 단계에서 60일 동안 고객 회신 없음

System
▶️ 다음 액션
📧 이메일 대화 전체 보기 ↓

단계 날짜 수정

단계 변경

단계 변경 사유와 다음 액션을 메모하세요.

단계 되돌리기

이전 단계로 되돌리는 사유를 메모하세요.

미팅 예약

미팅 일정을 등록합니다

미팅 예약 확정

예약 확정에 대한 메모를 선택적으로 남길 수 있습니다.

미팅 완료

딜 정보

미팅 후 새롭게 확인한 딜 정보가 있다면 수정하세요.

회사 정보

고객 프로필

수동 추가 (저장 시 딜 고객 연락처에 자동 등록)

Account Analysis 링크를 붙여넣거나 파일을 첨부하세요.

Meeting Transcript 링크를 붙여넣거나 파일을 첨부하세요.

미팅 취소

미팅을 취소하는 사유를 입력하세요. 필수 항목입니다.

미팅 수정

결제 완료 처리

정말 고객 결제가 완료되었나요?

이 동작은 되돌릴 수 없습니다.

AVOCADO HEALTH

Qualified Lost

업체 정보

업체 기본 정보입니다.

Contact
Andrew Logan
Email
andrew@avohealth.com
Country
United States (US) America/New_York
Phone
—

Deal Classification

Lead source and opportunity type for this deal.

Lead Source
AI OB
Opportunity Type
New Business

Business Type

딜 담당자가 직접 작성한 업체의 Business Type입니다.

Business Type
—
Business Subtype
—

AI Qualification

AI가 분류한 업체의 GTM 정보입니다.

GTM Segment
—
GTM Subsegment
—
Company Size
—
Company Products
—

Qualification (3/3)

Export Readiness
Commercially export-ready on EOQ/full-container basis; seasonal crop with constrained year‑round supply; Extra Virgin easier to supply year‑round than Crude; has Kenyan processing entity and NZ company
Buyer Acquisition Gap
low: receives 15–20 inbound buyer enquiries/week via website; does not want additional inbound from Tridge
Channel Development Intent
no interest in proactive market-development outreach; prefers inbound-only sourcing and to supply full-container (FCL) trials during seasonal windows

Company Profile (Pricing Intel)

Trade Volume
implied commercial-scale: EOQ/FCL shipments only; seasonal supply; Extra Virgin easier year‑round than Crude
Revenue Scale
Not inferred
Supply Chain Complexity
medium-high: seasonal sourcing windows, processing in Kenya, NZ corporate structure, handles both Extra Virgin and Crude oil
Detected Language
en

📡 Signals

▶ AI가 다른 고객과의 대화에서 포착한 extra virgin avocado oil, crude avocado oil 관련 수요·공급 시그널입니다. 이메일 응대, 미팅 시 시장 근거 자료로 활용해보세요.

💰 가격 점수

Tier
Tier 6
Price (USD)
$5799
Market Factor
3 / 3
Scale Factor
0 / 3
Value Factor
2 / 2
Complexity Factor
1 / 2

US buyer market is premium (Market=3). Company revenue/size not provided so treated as unknown/small (Scale=0); there is clear near-term action/need for buyer outreach and a 3–6 month trial window (Value=2), and product mix (extra virgin + crude avocado oil with seasonal supply) represents moderate complexity (Complexity=1).

생성: 2026-04-27T05:02:14Z

Conversation Summary

Andrew (AvoHealth) confirms supply is EOQ/FCL only and seasonally constrained; Extra Virgin easier to supply year‑round than Crude. He receives 15–20 inbound enquiries weekly and prefers no additional unsolicited inbound. Tridge will align outreach to full‑container trial terms; next step is to confirm specific supply months and whether container consolidation/multi‑buyer allocation is acceptable.

Next Topic

Confirm seasonal supply months and whether container consolidation/multi‑buyer allocation is acceptable so outreach engages only buyers able to take FCL trials.

Closed Lost

Reason Type
long_silence
Note
자동 종료: 제안서 전송 전 단계에서 60일 동안 고객 회신 없음

Email Thread (6)

→ 발신 sent rahman_shuvo1@tridge.com → andrew@avohealth.com (CC: "'AvoPro - Mohamud Keyse'" <mkeyse@avoprokenya.com>)
185d ago 보기
본문 보기
이전 메일 보기 ← 수신 · andrew@avohealth.com · 192d ago

Sales Committee Deliberation

rejection_or_disinterest high
Sensitive Topic Detected

Customer explicitly rejects Tridge's market-development offering and requests no further inbound inquiries; they state they already receive more buyer inquiries than they can fulfill.

"We certainly do not require any help with market development and I also don’t want any more inquiry from my website."

Agenda

Andrew explicitly rejected Tridge's market-development offering and requested 'no more inquiry from my website.' What should our next email to him say to honor his request while protecting the relationship and future engagement options?

A: Apologize and Cease Outreach

Send a brief apology, acknowledge his frustration, and confirm immediate suppression of all outbound marketing and buyer introductions to respect his request; ask one simple confirmation that this is acceptable and close the thread. This prioritizes de-escalation and compliance above all else.

B: Confirm Suppression + Opt‑in

Acknowledge and immediately stop active outreach, while offering a single low‑frequency opt‑in (e.g., quarterly market snapshot) that he can proactively subscribe to if useful; this preserves a light, permissioned channel for future value without sending unsolicited inquiries.

C: Pause Outreach + Disable Leads

Comply by pausing outreach and additionally remove or hide his contact from any Tridge public lead-capture channels so Tridge-originated buyer inquiries stop reaching him, while proposing a scheduled check-in window (e.g., 6–12 months) to confirm whether to re-enable outreach. This directly addresses the source of unwanted inquiries and keeps a clear re-engagement path.

Member Analyses
Relationship Advisor

Analysis: Andrew’s tone is frustrated and firm: he says he’s overwhelmed by unsolicited emails and buyer inquiries and explicitly asks for no more inquiries from his website, which reads as a clear stop request rather than a soft decline. Further unsolicited contact now would likely feel intrusive and damage trust; a short apology plus technical remediation will be more effective than persuasion. Given his direct style (NZ/Kenya-based owner sending blunt language), treat his words literally and avoid reading a polite ‘maybe later’ into them. This appears to be a genuine lack of interest in market-development outreach for now; preserve the relationship by respecting the request, removing the source of inbound leads, and leaving a simple, user-controlled path to opt back in if he ever wants to reconnect.

Recommendation: Recommend Option C but without the proactive 6–12 month check-in: immediately apologize, suppress active outbound marketing, and remove/hide his contact from Tridge’s public lead-capture channels so website-sourced inquiries stop; instead offer one clear, no-pressure way for him to re-enable contact if he chooses (e.g., reply "re-enable" or click an opt-in link).

Risk: The key risk is failing to stop website-sourced inquiries—any continued inbound leads will escalate his frustration and harm trust. Equally, proposing scheduled check-ins or a tenuous opt-in could be perceived as pressure and undo the goodwill of complying.

Value Strategist

Analysis: Andrew's firm has clear excess inbound demand and explicitly rejects market-development help, so Tridge's export-market offering is currently not a value fit for AvoHealth — our competitive buyer access would not deliver measurable ROI because they already have more inquiries than capacity. The immediate business value we can deliver instead is operational: stop unwanted lead noise and remove AvoHealth from any Tridge-originated public lead-capture flows, which can be framed as an investment in reputation protection and time savings for Andrew's team. The cost of not acting is tangible: continued Tridge-originated inquiries will erode trust, increase Andrew's operational burden handling irrelevant contacts, and could permanently close the door to future collaboration. Given those facts, the right tradeoff is to prioritize de-escalation plus root-cause remediation (remove/hide contact sources) while preserving a permissioned, low-effort re-entry path if they ever want it.

Recommendation: Pick Option C: comply immediately by pausing outreach and removing/hiding his contact from Tridge public lead-capture channels, but do not initiate unsolicited check-ins — instead schedule an internal review at 6–12 months to consider re-enabling outreach only if Andrew opts in. This directly solves his pain, protects the relationship, and leaves future opportunity intact without further bothering him.

Risk: Proposing any scheduled external check-in risks being read as continued outreach and may rekindle frustration; operationally, fully purging or hiding a contact across lead-capture systems can be complex and may require coordination across teams, creating execution risk.

Negotiation Tactician

Analysis: Andrew's reply is a genuine, explicit rejection and a deflection of value—he is frustrated by high inbound volume and clearly requests an immediate stop to website-originated inquiries. His BATNA is strong: AvoHealth is already oversubscribed (he says inquiries exceed annual capacity) and can ignore external market-development offers, so Tridge has low leverage right now. The optimal next move is immediate, visible compliance (apology + suppression of outreach and removal from Tridge lead-capture channels) while preserving a non‑intrusive, permissioned re‑entry path. This is not the time to push for meetings or follow-ups; instead we should show respect for his request and offer a clear opt‑in link and simple reactivation instructions should he want us later.

Recommendation: Choose Option C with a small modification: disable Tridge-originated lead capture to stop inbound website inquiries, send a short apology/confirmation email that you have suppressed outreach, and include a one‑click opt‑in for a low‑frequency update and clear instructions for re-enabling contact on his terms. Do not schedule future check‑ins automatically—leave reactivation under his control.

Risk: The main downside is losing a near-term commercial opportunity and any momentum from earlier engagement; Andrew may close the door permanently. A second risk is operational: failing to fully remove him from all capture channels could trigger another complaint and damage trust.

Final Decision

Adopt Option C with modifications recommended by the negotiation tactician and relationship advisor: immediately suppress outbound outreach, remove/hide Andrew's contact from all Tridge public lead‑capture channels, send a brief apology/confirmation email, and include a one‑click opt‑in for future low‑frequency updates; do NOT schedule external check‑ins — keep reactivation strictly on Andrew's terms. Internally, schedule a 6–12 month review to ensure the suppression remains effective and to evaluate whether re-enablement should be offered proactively only if Andrew opts in.

Approach: Send a concise apology/confirmation email immediately, perform the technical removal/hiding of his contact from all Tridge-originated public lead-capture sources, and include a clear, one-step opt-in path for future contact. Do not schedule any external check-ins; handle any internal review or monitoring of suppression status without contacting Andrew unless he opts back in.

Draft Opening: Hi Andrew — I'm sorry for the hassle; I’ve immediately suppressed Tridge outreach to AvoHealth and removed your contact from our website‑sourced lead lists so you will no longer receive Tridge‑originated buyer inquiries.

Key Arguments: 1) Immediate compliance: Confirm we have suppressed outreach and removed his contact from website lead flows — this stops the source of his complaint and protects the relationship. 2) Respect and de-escalation: A short apology and visible action shows respect and reduces the chance of further escalation. 3) Simple, user-controlled re-entry: Provide a one-click opt-in or a single-word reply ('re-enable') so he controls any future contact. 4) Operational assurance: Internally verify across systems that contact suppression is complete to avoid repeat inquiries. 5) No pressure or follow-ups: Reassure him there will be no scheduled check-ins or unsolicited messages unless he explicitly opts in.

Draft Closing: If you'd like to re-enable contact at any time, simply reply 're-enable' or click this one‑click opt‑in link and we will only resume outreach on your terms.

Tone: Concise, apologetic, respectful, and non‑defensive — prioritize clarity and brevity; avoid persuasive language or asking for justification.

Concession Boundary: What can be hinted at: offer a single, low-frequency, opt-in communication (e.g., quarterly market snapshot) and provide a one-click re-enable mechanism that Andrew controls. What is off-limits: any scheduled or proactive external check-ins, continued unsolicited outreach, automated lead-capture that sends Tridge-originated buyer inquiries to Andrew, offering discounts or special pricing, promising manual reports or deliverables, or mentioning/pressuring for meetings or calls.

Warnings: Do NOT send any follow-up emails attempting to persuade or reopen the conversation; do NOT schedule calls or meetings; do NOT promise manual reports or research; do NOT offer discounts or alternative commercial propositions; do NOT leave his contact in any public lead-capture system or partner lists; do NOT include urgency/pressure language; do NOT name or compare competitors.

Context Analyzer

Conversation Flow

Step 1: Rahman introduced the EU–Kenya EPA advantage for Kenyan processed avocado oil and suggested positioning Kenya for volume with New Zealand as a premium anchor; asked if AvoHealth is exploring export expansion. Step 2: Andrew sent a brief reply on 2026-04-18 with no visible message body. Step 3: Rahman followed up on 2026-04-21 describing buyer behavior (3–6 month trial cadence) and asked whether AvoHealth prefers scheduled monthly/biweekly shipments or ad-hoc/spot consolidation. Step 4: Rahman sent a near-duplicate follow-up a few minutes later reiterating the EPA update and the same cadence question. Step 5: Andrew replied on 2026-04-21 clarifying that shipment frequency does not matter to AvoHealth but every shipment must be an Economic Order Quantity (full containers); he also emphasized seasonality of the crop, the extra costs of year-round supply, and that Extra Virgin is easier to supply year-round than Crude Avocado Oil.

Customer Intent

Clarify commercial constraints: AvoHealth requires every shipment to be EOQ/full containers and is highlighting crop seasonality as a key constraint on year-round supply; he also distinguishes that Extra Virgin oil is easier to supply year‑round than Crude.

Sentiment

Practical, direct and engaged — focused on logistical and cost constraints rather than negotiation; informative rather than asking further questions.

Unanswered Questions

none

Pending Promises

none

Topic Context

'EU–Kenya EPA' → refers to the trade agreement (effective 1 July 2024) giving duty-free, quota-free access to Kenyan processed products, creating a tariff edge for Kenyan avocado oil; 'scheduled monthly/biweekly shipments' → buyer-preferred cadences Rahman asked about to accelerate trials, i.e., regular replenishment shipments; 'ad-hoc/spot consolidation' → supplying irregular, consolidated shipments rather than fixed cadence; 'EOQ / Full containers' → Andrew's requirement that each shipment must be an Economic Order Quantity (full-container load) due to fuel costs; 'seasonal crop' → Andrew's note that avocado supply is seasonal and requiring year-round supply increases costs; 'Extra Virgin vs Crude Avocado Oil' → Andrew's point that Extra Virgin is technically easier to supply year‑round than Crude.

Next Step Suggestion

Acknowledge and confirm understanding of the EOQ/full-container requirement, then ask for a seasonal supply calendar and typical full-container volumes per product (Extra Virgin vs Crude). Also propose how a 3–6 month trial could be structured around EOQ shipments and offer to map buyer expectations (traceability/COA) to those constraints.

← 수신 received 📎 1 andrew@avohealth.com → rahman_shuvo1@tridge.com (CC: "'AvoPro - Mohamud Keyse'" <mkeyse@avoprokenya.com>)
192d ago 보기
본문 보기
이전 메일 보기 → 발신 · rahman_shuvo1@tridge.com · 193d ago
→ 발신 sent rahman_shuvo1@tridge.com → andrew@avohealth.com
193d ago 보기
본문 보기
이전 메일 보기 → 발신 · rahman_shuvo1@tridge.com · 193d ago
→ 발신 sent rahman_shuvo1@tridge.com → andrew@avohealth.com (CC: "'AvoPro - Mohamud Keyse'" <mkeyse@avoprokenya.com>)
193d ago 보기
본문 보기
이전 메일 보기 ← 수신 · andrew@avohealth.com · 196d ago
Deal Created — 2026-04-18 13:31

아래의 메일 이력은 딜 생성 전에 고객과 주고받은 내역입니다. (최대 3개월 전까지의 내역만 불러옵니다)

← 수신 received 📎 3 andrew@avohealth.com → rahman_shuvo1@tridge.com (CC: "'AvoPro - Mohamud Keyse'" <mkeyse@avoprokenya.com>)
196d ago 보기
본문 보기
이전 메일 보기 → 발신 · rahman_shuvo1@tridge.com · 197d ago
→ 발신 sent rahman_shuvo1@tridge.com
197d ago 보기
본문 보기

최근 AI 작업

전체 보기
run-b440385b thread_developer_export completed
0 turns — 185d ago
run-869394b5 thread_developer_loop_export completed
0 turns — 187d ago
run-b38e1e1a thread_developer_export completed
0 turns — 187d ago
run-0d97d267 committee_chairperson completed
0 turns — 187d ago
run-be2fda5e committee_relationship_advisor completed
0 turns — 187d ago

고객 언어 수정

비워두면 고객 언어 값을 지웁니다.

딜 정보 수정

비워두면 현재 값이 유지됩니다.

업체 정보

업체 기본 정보입니다.

Business Type

딜 담당자가 직접 작성한 업체의 Business Type입니다.

AI Qualification

자동 분류 · 수정 불가

AI가 분류한 업체의 GTM 정보입니다. 수정이 필요하면 MQL, Playbook 업데이트를 실행하세요.

—
—
—
—

거래 방향 수정

앞으로 생성되는 이메일 초안에 이 거래 방향을 반영합니다.

Qualification 정보 수정

Qualification 정보

회사 프로필 (가격 산정 참고용)

메일 이력

⚠️ 참여자 제거

참여자를 이 딜에서 제거합니다.

제거 후 해당 참여자는 더 이상 이 딜에 접근할 수 없습니다.

⚠️ 연락처 제거

연락처를 이 딜에서 제거합니다.

제거 후 해당 연락처는 이 딜의 고객 연락처 목록에 표시되지 않습니다.

↺ 가격 다시 계산

현재 딜 정보를 기준으로 가격을 다시 계산합니다. 필요한 경우 추가 지침을 입력하세요.

입력하지 않으면 딜 정보만으로 계산합니다.

가격 점수 수정

Price (Annual USD) is auto-computed from the tier using the pricing table.

📨 Demo Sent 수동 처리

AVOCADO HEALTH 딜을 Demo Sent 상태로 전환합니다.

딜 다시 열기

AVOCADO HEALTH 딜을 다시 엽니다.

이전 단계로 복원됩니다. (discovery)
팔로업 카운터가 초기화되며, 이메일 수신 시 자동 초안 생성이 다시 동작합니다.

❌ Lost로 종료

딜을 Lost로 종료합니다. 이후 자동 초안 생성과 상태 변경이 중단됩니다.

🔄 딜 다시 열기

Lost 처리된 딜을 다시 엽니다. 직전 단계로 돌아갑니다.

이메일 초안 설정